Mesa Laboratories (NASDAQ:MLAB) CEO Purchases $800,090.40 in Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB) CEO Siddhartha Kadia acquired 7,093 shares of the stock in a transaction dated Thursday, August 13th. The shares were bought at an average price of $112.80 per share, for a total transaction of $800,090.40. Following the transaction, the chief executive officer owned 7,093 shares in the company, valued at approximately $800,090.40. This represents a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Mesa Laboratories Price Performance

MLAB traded up $2.15 during trading on Monday, reaching $108.19. The stock had a trading volume of 77,359 shares, compared to its average volume of 147,914. The stock has a market cap of $605.40 million, a PE ratio of 128.81 and a beta of 0.92. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.79. Mesa Laboratories, Inc. has a one year low of $58.83 and a one year high of $115.52. The business has a 50-day moving average of $100.64 and a 200-day moving average of $96.07.

Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings results on Monday, August 10th. The medical instruments supplier reported $2.68 earnings per share (EPS) for the quarter. Mesa Laboratories had a return on equity of 22.72% and a net margin of 1.92%.The firm had revenue of $60.14 million during the quarter.

Mesa Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Monday, August 31st will be given a $0.16 dividend. The ex-dividend date is Monday, August 31st. This represents a $0.64 dividend on an annualized basis and a yield of 0.6%. Mesa Laboratories’s payout ratio is presently 76.19%.

Institutional Trading of Mesa Laboratories

Several large investors have recently modified their holdings of the business. Ranger Investment Management L.P. purchased a new position in Mesa Laboratories during the 2nd quarter valued at $17,321,000. Diamond Hill Capital Management LLC Investment Advisor purchased a new position in shares of Mesa Laboratories during the second quarter valued at about $15,507,000. Boston Partners raised its stake in Mesa Laboratories by 2,009.5% in the third quarter. Boston Partners now owns 114,357 shares of the medical instruments supplier’s stock worth $7,664,000 after buying an additional 108,936 shares in the last quarter. Millennium Management LLC lifted its holdings in Mesa Laboratories by 131.9% in the third quarter. Millennium Management LLC now owns 133,817 shares of the medical instruments supplier’s stock worth $8,967,000 after buying an additional 76,107 shares during the period. Finally, Wasatch Advisors LP boosted its position in Mesa Laboratories by 125.8% during the 2nd quarter. Wasatch Advisors LP now owns 115,668 shares of the medical instruments supplier’s stock valued at $11,515,000 after acquiring an additional 64,435 shares in the last quarter. 90.60% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

MLAB has been the subject of a number of recent research reports. Wall Street Zen lowered shares of Mesa Laboratories from a “strong-buy” rating to a “buy” rating in a report on Saturday. Wells Fargo & Company lifted their target price on shares of Mesa Laboratories from $94.00 to $110.00 and gave the stock an “equal weight” rating in a research report on Friday. Finally, Weiss Ratings upgraded shares of Mesa Laboratories from a “sell (d)” rating to a “hold (c-)” rating in a research report on Tuesday, August 11th. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Mesa Laboratories currently has a consensus rating of “Hold” and a consensus price target of $110.00.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.